Philip C. Robinson

9.8k total citations · 2 hit papers
116 papers, 3.7k citations indexed

About

Philip C. Robinson is a scholar working on Rheumatology, Infectious Diseases and Nephrology. According to data from OpenAlex, Philip C. Robinson has authored 116 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Rheumatology, 29 papers in Infectious Diseases and 24 papers in Nephrology. Recurrent topics in Philip C. Robinson's work include Spondyloarthritis Studies and Treatments (37 papers), Rheumatoid Arthritis Research and Therapies (34 papers) and COVID-19 Clinical Research Studies (26 papers). Philip C. Robinson is often cited by papers focused on Spondyloarthritis Studies and Treatments (37 papers), Rheumatoid Arthritis Research and Therapies (34 papers) and COVID-19 Clinical Research Studies (26 papers). Philip C. Robinson collaborates with scholars based in Australia, United States and New Zealand. Philip C. Robinson's co-authors include Matthew A. Brown, Nicola Dalbeth, William J. Taylor, Jinoos Yazdany, Tony R. Merriman, Tony Kenna, Duncan Richards, Marc Feldmann, Helen Tanner and David Liew and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Philip C. Robinson

111 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

2013 627 citations Philip C. Robinson, Matthew A. Brown et al. profile →
Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis

2014 305 citations Mary‐Ellen Costello, Francesco Ciccia et al. profile →

Peers

Philip C. Robinson

RHEUM

IMMUN

NEPHR

Amita Aggarwal India

Ramnath Misra India

Der‐Yuan Chen Taiwan

Lorenzo Dagna Italy

Yingyos Avihingsanon Thailand

Mark A. Weiss United States

Abdurrahman Tufan Türkiye

Oliver Lenz United States

Laurent Chiche France

Jonathan Janes United States

Amita Aggarwal India

Philip C. Robinson

2.6k ×1.6

RHEUM

1.6k ×1.7

IMMUN

1.0k ×1.2

251 ×0.3

341 ×0.5

NEPHR

Citations per year, relative to Philip C. Robinson Philip C. Robinson (= 1×) peers Amita Aggarwal

Countries citing papers authored by Philip C. Robinson

Since Specialization

Citations

This map shows the geographic impact of Philip C. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip C. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip C. Robinson more than expected).

Fields of papers citing papers by Philip C. Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip C. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip C. Robinson. The network helps show where Philip C. Robinson may publish in the future.

Co-authorship network of co-authors of Philip C. Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of Philip C. Robinson. A scholar is included among the top collaborators of Philip C. Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip C. Robinson. Philip C. Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kragstrup, Tue Wenzel, Christopher McMaster, Pankti Reid, et al.. (2023). Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors. Drug Safety. 46(11). 1049–1071. 29 indexed citations

Robinson, Philip C., et al.. (2022). Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms. Current Rheumatology Reports. 24(10). 310–320. 14 indexed citations

Robinson, Philip C., David Liew, Helen Tanner, et al.. (2022). COVID-19 therapeutics: Challenges and directions for the future. Proceedings of the National Academy of Sciences. 119(15). e2119893119–e2119893119. 92 indexed citations

Kragstrup, Tue Wenzel, Bente Glintborg, Christopher McMaster, et al.. (2022). Waiting for JAK inhibitor safety data. RMD Open. 8(1). e002236–e002236. 64 indexed citations

Topless, Ruth, Ralph Green, Sarah Morgan, et al.. (2022). Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case–control analysis from the UK Biobank. BMJ Open. 12(8). e062945–e062945. 6 indexed citations

Nash, Peter, et al.. (2021). The Effect of Etanercept in Nonradiographic Axial Spondyloarthritis by Stratified C‐Reactive Protein Levels. ACR Open Rheumatology. 3(10). 699–706. 1 indexed citations

Robinson, Philip C., Robert Terkeltaub, Michael H. Pillinger, et al.. (2021). Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease. The American Journal of Medicine. 135(1). 32–38. 68 indexed citations

Curtis, Jeffrey R., Xiaofeng Zhou, David T. Rubin, et al.. (2021). Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study. The Journal of Rheumatology. 49(3). 320–329. 22 indexed citations

Sattui, Sebastian E., Jean W. Liew, Elizabeth R. Graef, et al.. (2020). Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Review of Clinical Immunology. 16(7). 659–666. 39 indexed citations

10.

Robinson, Philip C., David Liew, Jean W. Liew, et al.. (2020). The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19. Med. 1(1). 90–102. 88 indexed citations

11.

Bradbury, Linda A., Kelly Hollis, Benoît Gautier, et al.. (2018). Diffusion-weighted Imaging Is a Sensitive and Specific Magnetic Resonance Sequence in the Diagnosis of Ankylosing Spondylitis. The Journal of Rheumatology. 45(6). 771–778. 33 indexed citations

12.

Thomas, Gethin, Dana Willner, Philip C. Robinson, et al.. (2017). Genetic diagnostic profiling in axial spondyloarthritis: a real world study.. PubMed. 35(2). 229–233. 24 indexed citations

13.

Kenna, Tony, Philip C. Robinson, & Nigil Haroon. (2015). Endoplasmic reticulum aminopeptidases in the pathogenesis of ankylosing spondylitis. Queensland's institutional digital repository (The University of Queensland). 3 indexed citations

14.

Costello, Mary‐Ellen, Francesco Ciccia, Dana Willner, et al.. (2015). Brief report: intestinal dysbiosis in ankylosing spondylitis. Queensland's institutional digital repository (The University of Queensland). 9 indexed citations

15.

Costello, Mary‐Ellen, Philip C. Robinson, Helen Benham, & Matthew A. Brown. (2015). The intestinal microbiome in human disease and how it relates to arthritis and spondyloarthritis. Queensland's institutional digital repository (The University of Queensland).

16.

Robinson, Philip C., et al.. (2014). The safety and handling of low dose methotrexate: Myths and realities. 33(5). 68.

17.

Robinson, Philip C., Paul Bird, Nivene Saad, et al.. (2014). Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA). Queensland's institutional digital repository (The University of Queensland). 1 indexed citations

18.

Robinson, Philip C.. (2012). Recent advances in biological therapies in rheumatic diseases. Internal Medicine Journal. 42. 11–11. 2 indexed citations

19.

Robinson, Philip C., et al.. (2012). Dense genotyping of candidate genes identifies 16 new susceptibility loci in ankylosing spondylitis. Clinical and Experimental Rheumatology. 30(4). 602–602. 1 indexed citations

20.

Robinson, Philip C. & Lisa K. Stamp. (2009). Mainstreaming environment and climate change in the implementation of poverty reduction strategies. PubMed. 45(5). 1–302. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact